Skip to main content

8 Result(s)

within O Frankfurt Remove this filter

and

  1. No Access

    Article

    Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy

    Recent advances in purine analog-based combination chemotherapy and chemoimmunotherapy have significantly improved response rates and progression-free survival in patients with B-cell chronic lymphocytic leuke...

    S Faderl, A Ferrajoli, O Frankfurt, A Pettitt in Leukemia (2009)

  2. No Access

    Article

    Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma?

    CD34+ cell dose calculations are usually based on actual body weight (ABW). We have shown that ideal body weight (IBW) may provide a better basis for this in a small population of patients with hematologic mal...

    V Singh, J Krishnamurthy, S Duffey, R Meagher, M Villa… in Bone Marrow Transplantation (2009)

  3. No Access

    Article

    Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole

    Seventy-one allograft recipients receiving voriconazole, in whom complete clinical, microbiologic and pharmacokinetic data were available, were studied to determine the efficacy of voriconazole in preventing f...

    S Trifilio, S Singhal, S Williams, O Frankfurt, L Gordon… in Bone Marrow Transplantation (2007)

  4. Article

    Correction: Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?

    J Mehta, L I Gordon, M S Tallman, J N Winter, A M Evens… in Bone Marrow Transplantation (2006)

    Download PDF (55 KB) View Article

  5. Article

    Erratum: Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation

    Correction to: Bone Marrow Transplantation (2006) 37, 553–557. doi:10.1038/sj.bmt.1705282 (Erratum: Bone Marrow Transplantation (2006) 37, 1067. doi:10.1038/sj.bmt.1705361). The author name AM Evens was publis...

    S Singhal, L I Gordon, M S Tallman, J N Winter, A M Evens… in Bone Marrow Transplantation (2006)

    Download PDF (55 KB) View Article

  6. No Access

    Article

    Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?

    Sixty three patients aged 27–66 years (median 52) were allografted from HLA-matched sibling (n=47), 10 of 10 allele-matched unrelated (n=19), or one-antigen/allele-mismatched (n=7) donors aged 24–69 years (median...

    J Mehta, L I Gordon, M S Tallman, J N Winter, A O Evens… in Bone Marrow Transplantation (2006)

  7. Article

    Erratum: Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation

    Correction to: Bone Marrow Transplantation (2006) 37, 553–557. doi:10.1038/sj.bmt.1705282; published online 30 January 2006 Due to a typesetting error the figure legends of Figures 3 and 4 were published incor...

    S Singhal, L I Gordon, M S Tallman, J N Winter, A O Evens… in Bone Marrow Transplantation (2006)

    Download PDF (66 KB) View Article

  8. No Access

    Article

    Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation

    Whether the CD34+ and CD3+ cell doses in allogeneic HSCT should be estimated using actual (ABW) or ideal (IBW) body weight has never been definitively determined. We have shown that CD34+ cell doses based upon...

    S Singhal, L I Gordon, M S Tallman, J N Winter, A O Evens… in Bone Marrow Transplantation (2006)